摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-对甲苯基-4-(三氟甲基)苯磺酰胺 | 1286478-99-6

中文名称
N-对甲苯基-4-(三氟甲基)苯磺酰胺
中文别名
——
英文名称
4-trifluoromethyl-N-p-tolylbenzenesulfonamide
英文别名
N-(p-tolyl)-4-(trifluoromethyl)benzenesulfonamide;N-(4-methylphenyl)-4-(trifluoromethyl)benzenesulfonamide
N-对甲苯基-4-(三氟甲基)苯磺酰胺化学式
CAS
1286478-99-6
化学式
C14H12F3NO2S
mdl
——
分子量
315.316
InChiKey
WJOACWBVNLISIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    123.7-124.6 °C

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    54.6
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-对甲苯基-4-(三氟甲基)苯磺酰胺氢六氟锑酸盐potassium carbonate 作用下, 以 乙腈 为溶剂, 反应 16.17h, 生成 4-trifluoromethyl-N-(2-fluoropropyl)-N-(4-methylphenyl)benzenesulfonamide
    参考文献:
    名称:
    超强酸合成的叔苯磺酰胺和苯并硫丹作为选择性hCA IX抑制剂:旨在了解叔磺酰胺抑制的新模式†
    摘要:
    在超强酸HF–SbF 5中合成了一系列叔(氟化)苯磺酰胺。规避原位问题通过低温NMR实验证明亚胺离子的形成,采用串联的超强酸催化的交叉偶联反应来合成苯并硫磺酸类似物。测试了这些叔苯磺酰胺作为人碳酸酐酶的抑制剂(hCA,EC 4.2.1.1)。这些化合物没有抑制广泛的脱靶hCA II同工型,并且显示出对与肿瘤相关的碳酸酐酶同工型IX的强选择性。证明了抑制剂的电子和结构形状对选择性的显着影响,证实了这类磺酰胺类药物的非锌键结合抑制方式。这项工作可以鉴定出该系列中的高选择性hCA IX抑制剂。
    DOI:
    10.1039/c3ob41538d
  • 作为产物:
    参考文献:
    名称:
    A General Method for Palladium-Catalyzed Reactions of Primary Sulfonamides with Aryl Nonaflates
    摘要:
    A general method for Pd-catalyzed sulfonamidation of aryl nonafluorobutanesulfonates (aryl nonaflates) is described. A biaryl phosphine ligand, t-BuXPhos, formed the most active catalyst, and K3PO4 in tert-amyl alcohol was found to be the optimal base solvent combination for the reaction. The reaction conditions were tolerant of various functional groups such as cyano, nitro, ester, aldehyde, ketone, chloride, carbamate, and phenol. Heterocyclic aryl nonaflates were found to be suitable coupling partners. High yields of the coupled products were obtained from the reactions between inherently disfavored substrates such as electron-rich nonaflates and electron-poor sulfonamides. Kinetic data suggest reductive elimination to be the rate-limiting step for the reaction. The only limitation of this methodology that we have identified is the inability of 2,6-disubstituted aryl nonaflates to efficiently participate in the reaction.
    DOI:
    10.1021/jo200443u
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Redox Coupling of Nitroarenes with Sodium Sulfinates
    作者:Saiwen Liu、Ru Chen、Jin Zhang
    DOI:10.3390/molecules24071407
    日期:——
    A simple copper-catalyzed redox coupling of sodium sulfinates and nitroarenes is described. In this process, abundant and stable nitroarenes serve as both the nitrogen sources and oxidants, and sodium sulfinates act as both reactants and reductants. A variety of aromatic sulfonamides were obtained in moderate to good yields with broad substrate scope. No external additive is employed for this kind
    描述了亚磺酸钠和硝基芳烃的简单铜催化氧化还原偶联。在这个过程中,丰富而稳定的硝基芳烃既是氮源又是氧化剂,亚磺酸钠既是反应物又是还原剂。以中等至良好的收率和广泛的底物范围获得了多种芳香族磺酰胺。这种转化不使用外部添加剂。
  • Nitrosoarenes as Nitrogen Source for Generation of Sulfonamides with the Insertion of Sulfur Dioxide under <scp>Metal‐Free</scp> Conditions <sup>†</sup>
    作者:Xuefeng Wang、Yanmei Lin、Jin‐Biao Liu、Fu‐Sheng He、Yunyan Kuang、Jie Wu
    DOI:10.1002/cjoc.202000053
    日期:2020.10
    A metal‐free reaction of nitrosoarenes, aryldiazonium tetrafluoroborates, and sulfur dioxide under mild conditions is developed, giving rise to sulfonamides in moderate to good yields. This transformation proceeds efficiently at room temperature in the presence of cyclohexa‐1,4‐diene with a broad reaction scope. Good functional group compatibility is observed, including cyano, halo, and ester. A plausible
    在温和条件下开发了亚硝基芳烃,芳基重氮四氟硼酸盐和二氧化硫的无金属反应,从而以中等至良好的产率产生了磺酰胺。在具有宽反应范围的环己-1,4-二烯存在下,这种转化在室温下可有效进行。观察到良好的官能团相容性,包括氰基,卤素和酯。提出了一种可能的机制,其中涉及一个自由基过程,其中插入了二氧化硫,并且在转化过程中,环己-1,4-二烯用作还原剂。
  • A General Method for Palladium-Catalyzed Reactions of Primary Sulfonamides with Aryl Nonaflates
    作者:Shashank Shekhar、Travis B. Dunn、Brian J. Kotecki、Donna K. Montavon、Steven C. Cullen
    DOI:10.1021/jo200443u
    日期:2011.6.3
    A general method for Pd-catalyzed sulfonamidation of aryl nonafluorobutanesulfonates (aryl nonaflates) is described. A biaryl phosphine ligand, t-BuXPhos, formed the most active catalyst, and K3PO4 in tert-amyl alcohol was found to be the optimal base solvent combination for the reaction. The reaction conditions were tolerant of various functional groups such as cyano, nitro, ester, aldehyde, ketone, chloride, carbamate, and phenol. Heterocyclic aryl nonaflates were found to be suitable coupling partners. High yields of the coupled products were obtained from the reactions between inherently disfavored substrates such as electron-rich nonaflates and electron-poor sulfonamides. Kinetic data suggest reductive elimination to be the rate-limiting step for the reaction. The only limitation of this methodology that we have identified is the inability of 2,6-disubstituted aryl nonaflates to efficiently participate in the reaction.
  • Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulfonamides
    作者:Benoît Métayer、Agnès Martin-Mingot、Daniella Vullo、Claudiu. T. Supuran、Sébastien Thibaudeau
    DOI:10.1039/c3ob41538d
    日期:——
    did not inhibit the widespread off target hCA II isoform and showed strong selectivity toward tumor-associated carbonic anhydrase isoform IX. A dramatic effect of the electronic and structural shape of the inhibitors on selectivity was demonstrated, confirming the non-zinc-bonding mode of inhibition of this class of sulfonamides. This work allowed identifying a highly selective hCA IX inhibitor lead in
    在超强酸HF–SbF 5中合成了一系列叔(氟化)苯磺酰胺。规避原位问题通过低温NMR实验证明亚胺离子的形成,采用串联的超强酸催化的交叉偶联反应来合成苯并硫磺酸类似物。测试了这些叔苯磺酰胺作为人碳酸酐酶的抑制剂(hCA,EC 4.2.1.1)。这些化合物没有抑制广泛的脱靶hCA II同工型,并且显示出对与肿瘤相关的碳酸酐酶同工型IX的强选择性。证明了抑制剂的电子和结构形状对选择性的显着影响,证实了这类磺酰胺类药物的非锌键结合抑制方式。这项工作可以鉴定出该系列中的高选择性hCA IX抑制剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐